PoNS therapy shows promise for MS gait deficits
NEWTOWN, Pa. - Helius Medical Technologies, Inc. (NASDAQ:HSDT), a neurotech company with a market capitalization of $3.84 million, announced significant findings from the PoNS Therapeutic Experience ...
Investing28 天
Helius Medical secures Medicare payment rates for PoNS device
Additionally, Helius is preparing for FDA submission for stroke authorization and exploring the expansion of PoNS therapy for traumatic brain injury patients. This article was generated with the ...